Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

4
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
4
Structural Protein Function01:56

Structural Protein Function

30.1K
Structural proteins are a category of proteins responsible for functions ranging from cell shape and movement to providing support to major structures such as bones, cartilage, hair, and muscles. This group includes proteins such as collagen, actin, myosin, and keratin.
Collagen, the most abundant protein in mammals, is found throughout the body. In connective tissue, such as skin, ligaments, and tendons, it provides tensile strength and elasticity.  In bones and teeth, it mineralizes to...
30.1K
Structural Protein Function01:56

Structural Protein Function

3.3K
3.3K
Histone Variants at the Centromere02:30

Histone Variants at the Centromere

5.1K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
5.1K
Fruit Development, Structure, and Function01:58

Fruit Development, Structure, and Function

25.4K
Fruits form from a mature flower ovary. As seeds develop from the ovules contained within, the ovary wall undergoes a series of complex changes to form fruit. In some fruits, such as soybeans, the ovary wall dries; in other fruits, such as grapes, it remains fleshy. In some cases, organs other than the ovary contribute to fruit formation; such fruits are called accessory fruits.
25.4K
Structure and Function of Erythrocytes01:29

Structure and Function of Erythrocytes

6.2K
There are between 4.2 and 6 million erythrocytes, also known as red blood cells, in every microliter of blood. These cells are small, flattened biconcave discs with centers that are depressed.
The erythrocyte plasma membrane is associated with proteins such as spectrin, which forms a flexible cytoplasmic meshwork. This meshwork allows erythrocytes to twist, turn, become cup-shaped, and regain their biconcave shape as they pass through narrow capillaries. Additionally, erythrocytes can form...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biallelic Variants in MIMS1 Produce a Form of Spondyloepimetaphyseal Dysplasia With Tracheal Stenosis and Ectodermal Dysplasia (SEMDTSED).

American journal of medical genetics. Part A·2026
Same author

Implementing Genomic Medicine in Primary Care: A Convergent Mixed Method Case Study.

Journal of evaluation in clinical practice·2026
Same author

Transitions in interesting times.

American journal of human genetics·2025
Same author

Genotype-first assessment of presentation and penetrance of neurofibromatosis type 1, autosomal dominant polycystic kidney disease, and Marfan syndrome within the All of Us research program cohort.

Genetics in medicine : official journal of the American College of Medical Genetics·2025
Same author

Repair of Mutated <i>NF1</i> mRNA with Trans-Splicing Group I Intron Ribozymes.

Cancers·2025
Same author

DFMF: Harnessing spectral-spatial synergy for MR image segmentation through Dual-Task Feature Mining Framework.

Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society·2025

Related Experiment Video

Updated: Feb 13, 2026

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
10:17

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

23.4K

Neurofibromin (NF1) genetic variant structure-function analyses using a full-length mouse cDNA.

Deeann Wallis1, Kairong Li1, Hui Lui1

  • 1Department of Genetics, University of Alabama at Birmingham, Birmingham, AL.

Human Mutation
|March 10, 2018
PubMed
Summary

Researchers developed a new cell culture system to study the functional impact of genetic variants in the Neurofibromatosis type 1 (NF1) gene. This method helps understand how NF1 mutations affect neurofibromin protein function and Ras signaling.

Keywords:
cDNAexpression systemfunctional studiesneurofibromatosis type Ineurofibromin

More Related Videos

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.4K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.4K

Related Experiment Videos

Last Updated: Feb 13, 2026

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations
10:17

An Allele-specific Gene Expression Assay to Test the Functional Basis of Genetic Associations

Published on: November 3, 2010

23.4K
In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila
06:41

In Vivo Functional Study of Disease-associated Rare Human Variants Using Drosophila

Published on: August 20, 2019

14.4K
Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation
07:15

Determining the Likelihood of Variant Pathogenicity Using Amino Acid-level Signal-to-Noise Analysis of Genetic Variation

Published on: January 16, 2019

11.4K

Area of Science:

  • Genetics
  • Molecular Biology
  • Cell Biology

Background:

  • Neurofibromatosis type 1 (NF1) is a genetic disorder caused by mutations in the NF1 gene, which encodes neurofibromin.
  • Understanding the functional consequences of NF1 variants is crucial for diagnosis and treatment.

Purpose of the Study:

  • To establish a novel cell culture system for assessing the functional impact of NF1 genetic variants.
  • To evaluate the ability of engineered NF1 variants to produce functional neurofibromin and restore cellular activity.

Main Methods:

  • A heterologous cell culture expression system was developed using full-length mouse Nf1 cDNA (mNf1) in human cell lines.
  • Mutant cDNAs representing NF1 patient variants were created and tested for mature neurofibromin production and Nf1 activity restoration in NF1-/- cells.

Main Results:

  • The full-length mNf1 cDNA successfully produced a >250 kDa neurofibromin protein capable of modulating Ras signaling.
  • The study assessed various NF1 patient variants across multiple protein domains and predicted variant types.

Conclusions:

  • This new approach aids in understanding neurofibromin structure-function relationships.
  • It facilitates the determination of pathogenicity for missense variants and the development of targeted therapeutics for NF1.